Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Navigating the Intersection of Telehealth and Pharmaceutical Direct to Consumer (DTC) Activity

Date: Thursday, September 17, 2020 3:00 PM - 4:00 PM

Join us on September 17, 2020, for a focused discussion on key legal and compliance considerations for life science companies as they seek to integrate telehealth functionality into promotional DTC campaigns for their drugs and devices.

As COVID-19-related impacts have brought telehealth into the foreground to address patient access issues through remote physician consults, greater use of online screening tools, and facilitation of e-prescribing, many life science companies are now considering how telehealth could be integrated into their DTC efforts on an on-going basis. In particular, they are considering how to collaborate with a growing array of third-party platform providers that are aggregating telehealth prescriber networks, virtual pharmacies, and targeted digital marketing strategies.

Experts from Covington's Health Care, Digital Health, Life Sciences, and Technology and IP Transactions practices will discuss:

  • Fundamentals of state-level telehealth regulation and policy outlook
  • Use of physician-owned networks and implications for the corporate practice of medicine
  • Cost structures for new DTC telehealth models
  • Designing reimbursement and pharmacy support
  • FDA promotional considerations for DTC advertising
  • Navigating fraud and abuse risks
  • Considering product liability and patient safety concerns
  • Key transactional considerations for telehealth arrangements


Van Ellis
+1 2020 662 5734

Rujul Desai
Of Counsel
+1 202 662 5427

Stefanie Doebler
Of Counsel
+1 202 662 5271

Thursday, September 17, 2020
3 - 4 p.m. EDT
12 - 1 p.m. PDT

Log-in details will be provided upon registration.

Please note: CLE credit will be offered.

For additional information or to register, please contact Kara Lee.